People

Jerre Stead

Jerre Stead is a director of Amydis and founder and chairman of Stead Impact Ventures. He formerly led Clarivate and IHS Markit and has served as CEO or chairman of numerous public companies; his philanthropic work includes Alzheimer's research. Jerre Stead serves on Spinogenix’s board and chairs Stead Impact Ventures. His earlier business leadership includes Clarivate and IHS Markit, alongside philanthropic support for research into Alzheimer’s disease. Jerre Stead is co-founder and board chair of ALZpath, a blood-based Alzheimer’s diagnostics company founded in2020.